120 related articles for article (PubMed ID: 15583479)
1. Sudden death in Prader-Willi syndrome during growth hormone therapy.
Sacco M; Di Giorgio G
Horm Res; 2005; 63(1):29-32. PubMed ID: 15583479
[TBL] [Abstract][Full Text] [Related]
2. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report.
Eiholzer U; Nordmann Y; L'Allemand D
Horm Res; 2002; 58 Suppl 3():24-6. PubMed ID: 12435892
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
Fillion M; Deal C; Van Vliet G
J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
[TBL] [Abstract][Full Text] [Related]
4. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment.
Nagai T; Obata K; Tonoki H; Temma S; Murakami N; Katada Y; Yoshino A; Sakazume S; Takahashi E; Sakuta R; Niikawa N
Am J Med Genet A; 2005 Jul; 136(1):45-8. PubMed ID: 15937939
[TBL] [Abstract][Full Text] [Related]
5. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS.
Eiholzer U
Horm Res; 2005; 63(1):33-9. PubMed ID: 15604598
[TBL] [Abstract][Full Text] [Related]
6. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
[TBL] [Abstract][Full Text] [Related]
7. Sudden death in growth hormone-treated children with Prader-Willi syndrome.
Van Vliet G; Deal CL; Crock PA; Robitaille Y; Oligny LL
J Pediatr; 2004 Jan; 144(1):129-31. PubMed ID: 14722532
[TBL] [Abstract][Full Text] [Related]
8. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
9. Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
Kuramochi Y; Kato T; Sudou M; Sugano H; Takagi H; Morita T
Lupus; 2007; 16(6):447-9. PubMed ID: 17664237
[TBL] [Abstract][Full Text] [Related]
10. Sudden death of an infant with Prader-Willi syndrome--not a unique case?
Nordmann Y; Eiholzer U; l'Allemand D; Mirjanic S; Markwalder C
Biol Neonate; 2002 Aug; 82(2):139-41. PubMed ID: 12169838
[TBL] [Abstract][Full Text] [Related]
11. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
14. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
[TBL] [Abstract][Full Text] [Related]
15. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
Bakker B; Maneatis T; Lippe B
Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
[No Abstract] [Full Text] [Related]
16. Prader-Willi syndrome: who can have growth hormone?
Stafler P; Wallis C
Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
18. Sudden death of a girl with Prader-Willi syndrome.
Oiglane E; Ounap K; Bartsch O; Rein R; Talvik T
Genet Couns; 2002; 13(4):459-64. PubMed ID: 12558118
[TBL] [Abstract][Full Text] [Related]
19. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study.
Grugni G; Crinò A; Bosio L; Corrias A; Cuttini M; De Toni T; Di Battista E; Franzese A; Gargantini L; Greggio N; Iughetti L; Livieri C; Naselli A; Pagano C; Pozzan G; Ragusa L; Salvatoni A; Trifirò G; Beccaria L; Bellizzi M; Bellone J; Brunani A; Cappa M; Caselli G; Cerioni V; Delvecchio M; Giardino D; Iannì F; Memo L; Pilotta A; Pomara C; Radetti G; Sacco M; Sanzari A; Sartorio A; Tonini G; Vettor R; Zaglia F; Chiumello G;
Am J Med Genet A; 2008 Apr; 146A(7):861-72. PubMed ID: 18203198
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
Carrel AL; Allen DB
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
